| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glycobiology vol 7 no 8 pp. 1237-1246, 1997
© 1997
Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase
o
Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, UNIFESP Rua Botucatn 862, 8° andar, 04023-062, São Paulo, S.P. Brazil
1 Laboratório de Xenodiagnóstico-Instituto Dante Pazzanese de Cardiologia São Paulo, Brazil
2 Department of Medical and Molecular Parasitology, New York University Medical Center New York, NY, 10010 USA
3To whom correspondence should be addressed at Disciplina de Biologia Celular, R. Botucatu 862 8* 04023-062 Sãb Paulo, S.P. Brazil
Received on April 28, 1997; revised on July 2, 1997; accepted on July 2, 1997
Trypanosoma cruzi, the agent of Chagas disease, expresses on its surface a trans-sialidase that catalyzes preferentially the transference of
-2,3-linked sialic acid to acceptors containing terminal β-galactosyl residues, instead of the typical hydrolysis reaction, found in most sialidases. The trans-sialidase is responsible for the acquisition of the host sialic acid by this protozoan parasite, which does not synthesize sialic acids. Here, we have studied some kinetic properties of a recombinant trans-sialidase expressed in Escherichia coli We found that it has sequential-type kinetics for the transferase reaction, as shown for the parasite-derived enzyme. The rates of sialic acid transfer to water (hydrolysis), and to β-galactosyl residues have a unique behavior with respect to the reaction temperature. While the hydrolysis rate of sialyUactose increases continuously up to 35°C, the temperature for the maximal rate of trans-glycosylation depends on the acceptor concentration. At low acceptor concentrations the rate of trans-glycosylation is maximal at 13°C and independent of the amount of sialic acid donors. With increasing acceptor concentrations, maximal rates of trans-glycosylation are shifted to higher temperatures. This finding is explained by an 8-fold increase in the Km for the acceptor from 13°C to 33°C. Differences in hydrolysis and transfer rates were also obtained by using 4-methyl-umbelliferyl-N-acetyl-neuraminic acid. However, its hydrolysis rate is much higher than the rate of transference to lactose, suggesting that a long-lived enzyme-sialosyl intermediate is not formed. In addition, lactose does not increase the rate of methyl-umbelliferone release at any temperature, indicating that the rate limiting step is the aglycon release. Based on these results we propose that trans-glycosylation in T.cruzi sialidase is favored by the existence of a binding site for β-galactosyl residues, which accepts the new glycosidic bond as sialic acid is released from the donor. With increasing temperature the affinity for the acceptor decreases, resulting in a concomitant increase in the rate of transfer to water, which, in turn, can be suppressed by increasing the acceptor concentration.
Trypanosoma cruzi sialidase kinetics reaction mechanism temperature
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Garcia, C. O. Ramos, J. F. V. Senra, F. Vilas-Boas, M. M. Rodrigues, A. C. Campos-de-Carvalho, R. Ribeiro-dos-Santos, and M. B. P. Soares Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1521 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Haselhorst, J. C. Wilson, A. Liakatos, M. J. Kiefel, J. C. Dyason, and M. von Itzstein NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi Glycobiology, October 1, 2004; 14(10): 895 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Agusti, G. Paris, L. Ratier, A. C.C. Frasch, and R. M. de Lederkremer Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo Glycobiology, July 1, 2004; 14(7): 659 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Todeschini, W. B. Dias, M. F. Girard, J.-M. Wieruszeski, L. Mendonca-Previato, and J. O. Previato Enzymatically Inactive trans-Sialidase from Trypanosoma cruzi Binds Sialyl and {beta}-Galactopyranosyl Residues in a Sequential Ordered Mechanism J. Biol. Chem., February 13, 2004; 279(7): 5323 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Pereira-Chioccola, A. A. Fragata-Filho, A. M. d. A. Levy, M. M. Rodrigues, and S. Schenkman Enzyme-Linked Immunoassay Using Recombinant trans-Sialidase of Trypanosoma cruzi Can Be Employed for Monitoring of Patients with Chagas' Disease after Drug Treatment Clin. Vaccine Immunol., September 1, 2003; 10(5): 826 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Fujimura, S. S. Kinoshita, V. L. Pereira-Chioccola, and M. M. Rodrigues DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene Infect. Immun., September 1, 2001; 69(9): 5477 - 5486. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paris, M. L. Cremona, M. F. Amaya, A. Buschiazzo, S. Giambiagi, A. C.C. Frasch, and P. M. Alzari Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity Glycobiology, April 1, 2001; 11(4): 305 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Todeschini, L. Mendonca-Previato, J. O. Previato, A. Varki, and H. v. Halbeek Trans-sialidase from Trypanosoma cruzi catalyzes sialoside hydrolysis with retention of configuration Glycobiology, February 1, 2000; 10(2): 213 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pereira-Chioccola, A Acosta-Serrano, I Correia de Almeida, M. Ferguson, T Souto-Padron, M. Rodrigues, L. Travassos, and S Schenkman Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies J. Cell Sci., January 4, 2000; 113(7): 1299 - 1307. [Abstract] [PDF] |
||||
![]() |
M. M. Rodrigues, M. Ribeirao, V. Pereira-Chioccola, L. Renia, and F. Costa Predominance of CD4 Th1 and CD8 Tc1 Cells Revealed by Characterization of the Cellular Immune Response Generated by Immunization with a DNA Vaccine Containing a Trypanosoma cruzi Gene Infect. Immun., August 1, 1999; 67(8): 3855 - 3863. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Abuin, L. H. G. Freitas-Junior, W. Colli, M. J. M. Alves, and S. Schenkman Expression of trans-Sialidase and 85-kDa Glycoprotein Genes in Trypanosoma cruzi Is Differentially Regulated at the Post-transcriptional Level by Labile Protein Factors J. Biol. Chem., May 7, 1999; 274(19): 13041 - 13047. [Abstract] [Full Text] [PDF] |
||||





